@PEACH_Study1

Procalcitonin: Evaluation of Antibiotic use in COVID-19 Hospitalised patients. @UniversityLeeds and @CTRCardiffUni

Leeds and Cardiff
Joined November 2020
Latest publication from ⁦@PEACH_Study1⁩ Cost-effectiveness of procalcitonin for guiding antibiotic prescribing in individuals hospitalized with COVID-19: part of the PEACH study | Journal of Antimicrobial Chemotherapy | Oxford Academic academic.oup.com/jac/advance…
3
4
358
Great to share our work on @PEACH_Study1 on #procalcitonin shortening antibiotic course length during #Covid #ECCMID2024 or #ESCMIDGlobal
4
8
679
Replying to @PEACH_Study1
@PEACH_Study1 is an excellent example of using diagnostics to reduce inappropriate antibiotics use during a viral pandemic outbreak @glgamr #eccmid2024 #escmidglobal
Last day of (usual) work before I head to Barcelona tomorrow for @ESCMID. Looking forward to seeing some colleagues and presenting the results of @PEACH_Study1 with @emma_tj1.
2
7
260
And we are here @ESCMID about to go to a sepsis talk by Mervyn Singer and then present the results of our @PEACH_Study1.
1
2
9
240
We’re looking forward to presenting results of the @PEACH_Study1 at @ECCMID in Barcelona next month. Thank you to everyone who was involved. @j_sandoe @CarrolEnitan @emma_tj1 @Dr_JoanneEuden @DetelinaGrozeva @WMaboshe @LBrookesHowell Josie Henley, Phil Pallmann & many more!
1
2
9
186
It’s the end of #WAAW2023 & we’ve been highlighting work from our infections division at @CTRCardiffUni. #AMR & antimicrobial stewardship needs to be at forefront of our minds. We need better diagnostics, implemented quickly once evidence exists for better patient outcomes.
4
10
433
We have just about finished analysis for @PEACH_Study1 (Procalcitonin evaluation of antibiotic use in COVID-19 hospitalised patients). Make sure you follow for updates, results and dissemination activities. #WAAW2023 @CarrolEnitan @j_sandoe @NIHRresearch @UniversityLeeds
1
2
6
459
Alot of work ongoing in the background to get manuscripts submitted. We have an incredibly rich repository of clinical data which reflects the huge effort from all our participating Trusts. We look forward to sharing the results of this study with you over the next few months.
2
4
702
We have finished all analysis. We hope to have main results of @PEACH_Study1 published very soon alongside our qualitative and health economics papers. cardiff.ac.uk/centre-for-tri… @j_sandoe @CarrolEnitan @AntibioticLeeds @MartinLlewelyn @LBrookesHowell @emma_tj1 @Dr_JoanneEuden
1
8
16
1,186
Thank you to all our sites for participating in the close down process. All sites are now closed. Analysis of data is almost complete and we look forward to sharing the results in due course.
5
118
Looking forward to presenting the results of our study at an internal @CTRCardiffUni meeting this week with @CarrolEnitan, and with our wider investigator group next month. Thank you again to all site staff who worked so hard to gather patient data for this study. #ICTD2023
1
5
327
Tomorrow is #ICTD2023 and a great way to roll into next week when we discuss results of @PEACH_Study1, @BATCH_trial, @PRECISE_study and finalise plans for our first PROTECT stakeholder meeting in Leeds with @CarrolEnitan and @CTRCardiffUni colleagues.
3
5
414
Thank you to our sites for your cooperation during the close down process. Half have officially been closed. We are continuing to analyse our main work package and will publish our results within the next couple of months.
1
3
78
“It was admirable that the team were committed to such early involvement.” - Margaret, co-applicant Learn more about how the @PEACH_Study1 involved public contributors and how those involved found the experience: nihr.ac.uk/documents/case-st…
5
8
887